These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 714379)

  • 21. [The treatment of dry eye with Lacrisert].
    Cordonnier M; Pereleux A; Herode A; Zanen A
    Bull Soc Belge Ophtalmol; 1984-1985; 212():65-9. PubMed ID: 6545879
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of keratoconjunctivitis sicca (author's transl)].
    van Bijsterveld OP; Westers JC
    Klin Monbl Augenheilkd; 1980 Jul; 177(1):52-7. PubMed ID: 7453037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Artificial tear solutions.
    Lemp MA
    Int Ophthalmol Clin; 1973; 13(1):221-9. PubMed ID: 4724258
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of pH and osmolarity on the ability of tolerate artificial tears.
    Motolko M; Breslin CW
    Am J Ophthalmol; 1981 Jun; 91(6):781-4. PubMed ID: 7246701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of two preservative-free tear substitutes in the management of severe dry eye.
    Laflamme MY; Swieca R
    Can J Ophthalmol; 1988 Jun; 23(4):174-6. PubMed ID: 3395921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxypropylmethylcellulose in the treatment of the dry eye.
    Molemans M; Maudgal PC; Missotten L
    Bull Soc Belge Ophtalmol; 1982; 201():93-7. PubMed ID: 7187263
    [No Abstract]   [Full Text] [Related]  

  • 27. [Dry eye syndrome in patients with biliary cirrhosis].
    Holló G; Szalay F
    Orv Hetil; 1992 Aug; 133(35):2217-20. PubMed ID: 1528584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of keratoconjunctivitis sicca with Lacrisert.
    Prause JU
    Scand J Rheumatol Suppl; 1986; 61():261-3. PubMed ID: 3296154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tear film breakup time prolonged with unmedicated cellulose polymer inserts.
    Gautheron PD; Lotti VJ; Le Douarec JC
    Arch Ophthalmol; 1979 Oct; 97(10):1944-7. PubMed ID: 485922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxypropyl cellulose ophthalmic inserts (lacrisert) reduce the signs and symptoms of dry eye syndrome and improve patient quality of life.
    McDonald M; D'Aversa G; Perry HD; Wittpenn JR; Donnenfeld ED; Nelinson DS
    Trans Am Ophthalmol Soc; 2009 Dec; 107():214-21. PubMed ID: 20126497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tear film: new concepts and implications for the management of the dry eye.
    Lemp MA
    Trans New Orleans Acad Ophthalmol; 1987; 35():53-64. PubMed ID: 3441945
    [No Abstract]   [Full Text] [Related]  

  • 32. Beneficial effect of topical fibronectin in patients with keratoconjunctivitis sicca of Sjögren's syndrome.
    Kono I; Matsumoto Y; Kono K; Ishibashi Y; Narushima K; Kabashima T; Yamane K; Sakurai T; Kashiwagi H
    J Rheumatol; 1985 Jun; 12(3):487-9. PubMed ID: 4045849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical performance of a mid-viscosity artificial tear for dry eye treatment.
    Simmons PA; Vehige JG
    Cornea; 2007 Apr; 26(3):294-302. PubMed ID: 17413956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a physiological tear substitute in patients with keratoconjunctivitis sicca.
    Nelson JD; Drake MM; Brewer JT; Tuley M
    Adv Exp Med Biol; 1994; 350():453-7. PubMed ID: 8030518
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative study of treatment of the dry eye syndrome due to disturbances of the tear film lipid layer with lipid-containing tear substitutes].
    Dausch D; Lee S; Dausch S; Kim JC; Schwert G; Michelson W
    Klin Monbl Augenheilkd; 2006 Dec; 223(12):974-83. PubMed ID: 17199193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An improved method for the delivery of artificial tears using an infusion pump.
    Karesh JW; Nirankari VS
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1284-8. PubMed ID: 3733371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
    Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK
    Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetylcysteine treatment of keratitis sicca.
    Messner K; Leibowitz HM
    Arch Ophthalmol; 1971 Sep; 86(3):357-9. PubMed ID: 5095560
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnosis and management of dry eyes.
    Wright P
    Trans Ophthalmol Soc U K (1962); 1971; 91():119-28. PubMed ID: 5291517
    [No Abstract]   [Full Text] [Related]  

  • 40. Contrast sensitivity and tear layer aberrometry in dry eye patients.
    Ridder WH; LaMotte J; Hall JQ; Sinn R; Nguyen AL; Abufarie L
    Optom Vis Sci; 2009 Sep; 86(9):E1059-68. PubMed ID: 19648840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.